OrthoPediatrics Corp. (NASDAQ: KIDS) Stock Competitors & Peer Comparison
See KIDS's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for KIDS and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KIDS | $23.19 | +1.55% | 584.8M | -19.30 | -$1.18 | N/A |
| ABT | $108.67 | +0.65% | 186.5B | 20.69 | $5.21 | +2.31% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $341.86 | +1.31% | 130B | 25.32 | $13.39 | +1.03% |
| MDT | $88.73 | +3.27% | 111.6B | 15.76 | $5.53 | +3.29% |
| BSX | $50.58 | +2.60% | 73.3B | 15.91 | $3.10 | N/A |
| EW | $92.12 | +3.13% | 51.7B | 33.23 | $2.70 | N/A |
| DXCM | $87.64 | +5.56% | 32B | 36.37 | $2.33 | N/A |
| RMD | $219.50 | -1.68% | 30.7B | 19.68 | $10.77 | +1.15% |
| PHG | $26.92 | +2.22% | 26.1B | 15.28 | $1.75 | +3.70% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
KIDS vs ABT Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, ABT has a market cap of 186.5B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while ABT trades at $108.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas ABT's P/E ratio is 20.69. In terms of profitability, KIDS's ROE is -0.12%, compared to ABT's ROE of +0.11%. Regarding short-term risk, KIDS is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
KIDS vs BSX-PA Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, KIDS's ROE is -0.12%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, KIDS is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
KIDS vs SYK Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, SYK has a market cap of 130B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while SYK trades at $341.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas SYK's P/E ratio is 25.32. In terms of profitability, KIDS's ROE is -0.12%, compared to SYK's ROE of +0.16%. Regarding short-term risk, KIDS is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check SYK's competition here
Medtronic plc (NYSE: MDT)
KIDS vs MDT Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, MDT has a market cap of 111.6B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while MDT trades at $88.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas MDT's P/E ratio is 15.76. In terms of profitability, KIDS's ROE is -0.12%, compared to MDT's ROE of +0.10%. Regarding short-term risk, KIDS is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
KIDS vs BSX Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, BSX has a market cap of 73.3B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while BSX trades at $50.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas BSX's P/E ratio is 15.91. In terms of profitability, KIDS's ROE is -0.12%, compared to BSX's ROE of +0.15%. Regarding short-term risk, KIDS is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
KIDS vs EW Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, EW has a market cap of 51.7B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while EW trades at $92.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas EW's P/E ratio is 33.23. In terms of profitability, KIDS's ROE is -0.12%, compared to EW's ROE of +0.10%. Regarding short-term risk, KIDS is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
KIDS vs DXCM Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, DXCM has a market cap of 32B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while DXCM trades at $87.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas DXCM's P/E ratio is 36.37. In terms of profitability, KIDS's ROE is -0.12%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, KIDS is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
KIDS vs RMD Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, RMD has a market cap of 30.7B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while RMD trades at $219.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas RMD's P/E ratio is 19.68. In terms of profitability, KIDS's ROE is -0.12%, compared to RMD's ROE of +0.24%. Regarding short-term risk, KIDS is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
KIDS vs PHG Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, PHG has a market cap of 26.1B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while PHG trades at $26.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas PHG's P/E ratio is 15.28. In terms of profitability, KIDS's ROE is -0.12%, compared to PHG's ROE of +0.10%. Regarding short-term risk, KIDS is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
KIDS vs ZBH Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, ZBH has a market cap of 18.7B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while ZBH trades at $96.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas ZBH's P/E ratio is 11.38. In terms of profitability, KIDS's ROE is -0.12%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, KIDS is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
KIDS vs ABMD Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas ABMD's P/E ratio is 65.36. In terms of profitability, KIDS's ROE is -0.12%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, KIDS is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
KIDS vs PEN Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, PEN has a market cap of 12.8B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while PEN trades at $326.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas PEN's P/E ratio is 84.77. In terms of profitability, KIDS's ROE is -0.12%, compared to PEN's ROE of +0.11%. Regarding short-term risk, KIDS is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
KIDS vs SNN Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, SNN has a market cap of 12.6B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while SNN trades at $29.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas SNN's P/E ratio is 14.16. In terms of profitability, KIDS's ROE is -0.12%, compared to SNN's ROE of +0.12%. Regarding short-term risk, KIDS is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check SNN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
KIDS vs SWAV Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas SWAV's P/E ratio is 78.76. In terms of profitability, KIDS's ROE is -0.12%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, KIDS is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
KIDS vs ALGN Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, ALGN has a market cap of 12.4B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while ALGN trades at $175.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas ALGN's P/E ratio is 15.83. In terms of profitability, KIDS's ROE is -0.12%, compared to ALGN's ROE of +0.14%. Regarding short-term risk, KIDS is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
KIDS vs GMED Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, GMED has a market cap of 11.1B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while GMED trades at $84.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas GMED's P/E ratio is 18.56. In terms of profitability, KIDS's ROE is -0.12%, compared to GMED's ROE of +0.12%. Regarding short-term risk, KIDS is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
KIDS vs GKOS Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, GKOS has a market cap of 10.6B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while GKOS trades at $181.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas GKOS's P/E ratio is -209.45. In terms of profitability, KIDS's ROE is -0.12%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, KIDS is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
KIDS vs PODD Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, PODD has a market cap of 9.8B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while PODD trades at $142.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas PODD's P/E ratio is 24.05. In terms of profitability, KIDS's ROE is -0.12%, compared to PODD's ROE of +0.27%. Regarding short-term risk, KIDS is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
KIDS vs BIO-B Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, BIO-B has a market cap of 9.5B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while BIO-B trades at $349.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas BIO-B's P/E ratio is 103.54. In terms of profitability, KIDS's ROE is -0.12%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, KIDS is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
KIDS vs BIO Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, BIO has a market cap of 9.5B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while BIO trades at $350.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas BIO's P/E ratio is 38.00. In terms of profitability, KIDS's ROE is -0.12%, compared to BIO's ROE of +0.03%. Regarding short-term risk, KIDS is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check BIO's competition here
Masimo Corporation (NASDAQ: MASI)
KIDS vs MASI Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas MASI's P/E ratio is 44.43. In terms of profitability, KIDS's ROE is -0.12%, compared to MASI's ROE of +0.09%. Regarding short-term risk, KIDS is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
KIDS vs BRKR Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, BRKR has a market cap of 8.1B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while BRKR trades at $56.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas BRKR's P/E ratio is 26.84. In terms of profitability, KIDS's ROE is -0.12%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, KIDS is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check BRKR's competition here
Inari Medical, Inc. (NASDAQ: NARI)
KIDS vs NARI Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas NARI's P/E ratio is -59.24. In terms of profitability, KIDS's ROE is -0.12%, compared to NARI's ROE of -0.00%. Regarding short-term risk, KIDS is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
KIDS vs ITGR Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while ITGR trades at $125.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas ITGR's P/E ratio is 19.72. In terms of profitability, KIDS's ROE is -0.12%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, KIDS is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
KIDS vs IRTC Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, IRTC has a market cap of 4.2B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while IRTC trades at $125.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas IRTC's P/E ratio is -199.75. In terms of profitability, KIDS's ROE is -0.12%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, KIDS is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check IRTC's competition here
LivaNova PLC (NASDAQ: LIVN)
KIDS vs LIVN Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while LIVN trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas LIVN's P/E ratio is 18.10. In terms of profitability, KIDS's ROE is -0.12%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, KIDS is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check LIVN's competition here
Haemonetics Corporation (NYSE: HAE)
KIDS vs HAE Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, HAE has a market cap of 4B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while HAE trades at $86.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas HAE's P/E ratio is 17.54. In terms of profitability, KIDS's ROE is -0.12%, compared to HAE's ROE of +0.11%. Regarding short-term risk, KIDS is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check HAE's competition here
Axonics, Inc. (NASDAQ: AXNX)
KIDS vs AXNX Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas AXNX's P/E ratio is -709.80. In terms of profitability, KIDS's ROE is -0.12%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, KIDS is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
KIDS vs TMDX Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while TMDX trades at $86.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas TMDX's P/E ratio is 42.58. In terms of profitability, KIDS's ROE is -0.12%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, KIDS is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
KIDS vs AXGN Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, AXGN has a market cap of 2.5B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while AXGN trades at $47.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas AXGN's P/E ratio is 122.18. In terms of profitability, KIDS's ROE is -0.12%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, KIDS is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
KIDS vs UFPT Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, UFPT has a market cap of 2.4B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while UFPT trades at $318.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas UFPT's P/E ratio is 32.07. In terms of profitability, KIDS's ROE is -0.12%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, KIDS is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
KIDS vs BFLY Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, BFLY has a market cap of 2.3B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while BFLY trades at $9.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas BFLY's P/E ratio is -36.77. In terms of profitability, KIDS's ROE is -0.12%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, KIDS is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check BFLY's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
KIDS vs ESTA Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, ESTA has a market cap of 2.3B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while ESTA trades at $76.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas ESTA's P/E ratio is -61.44. In terms of profitability, KIDS's ROE is -0.12%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, KIDS is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
KIDS vs NUVA Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas NUVA's P/E ratio is 75.00. In terms of profitability, KIDS's ROE is -0.12%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, KIDS is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
KIDS vs NVCR Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while NVCR trades at $17.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas NVCR's P/E ratio is -10.71. In terms of profitability, KIDS's ROE is -0.12%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, KIDS is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
KIDS vs INSP Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, INSP has a market cap of 1.7B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while INSP trades at $60.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas INSP's P/E ratio is 26.51. In terms of profitability, KIDS's ROE is -0.12%, compared to INSP's ROE of +0.18%. Regarding short-term risk, KIDS is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
KIDS vs TNDM Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, TNDM has a market cap of 1.5B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while TNDM trades at $22.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas TNDM's P/E ratio is -20.35. In terms of profitability, KIDS's ROE is -0.12%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, KIDS is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check TNDM's competition here
Enovis Corporation (NYSE: ENOV)
KIDS vs ENOV Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while ENOV trades at $25.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas ENOV's P/E ratio is 7.62. In terms of profitability, KIDS's ROE is -0.12%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, KIDS is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check ENOV's competition here
CONMED Corporation (NYSE: CNMD)
KIDS vs CNMD Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while CNMD trades at $49.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas CNMD's P/E ratio is 10.78. In terms of profitability, KIDS's ROE is -0.12%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, KIDS is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
KIDS vs ATEC Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, ATEC has a market cap of 1.4B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while ATEC trades at $9.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas ATEC's P/E ratio is -155.17. In terms of profitability, KIDS's ROE is -0.12%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, KIDS is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check ATEC's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
KIDS vs IART Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while IART trades at $17.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas IART's P/E ratio is 7.31. In terms of profitability, KIDS's ROE is -0.12%, compared to IART's ROE of -0.01%. Regarding short-term risk, KIDS is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
KIDS vs AORT Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while AORT trades at $26.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas AORT's P/E ratio is 45.28. In terms of profitability, KIDS's ROE is -0.12%, compared to AORT's ROE of -0.01%. Regarding short-term risk, KIDS is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
KIDS vs HSKA Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas HSKA's P/E ratio is -62.49. In terms of profitability, KIDS's ROE is -0.12%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, KIDS is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check HSKA's competition here
IRadimed Corporation (NASDAQ: IRMD)
KIDS vs IRMD Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while IRMD trades at $91.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas IRMD's P/E ratio is 46.48. In terms of profitability, KIDS's ROE is -0.12%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, KIDS is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check IRMD's competition here
Avanos Medical, Inc. (NYSE: AVNS)
KIDS vs AVNS Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas AVNS's P/E ratio is 27.77. In terms of profitability, KIDS's ROE is -0.12%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, KIDS is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check AVNS's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
KIDS vs PRCT Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while PRCT trades at $21.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas PRCT's P/E ratio is -10.52. In terms of profitability, KIDS's ROE is -0.12%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, KIDS is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check PRCT's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
KIDS vs SILK Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas SILK's P/E ratio is -18.96. In terms of profitability, KIDS's ROE is -0.12%, compared to SILK's ROE of -0.35%. Regarding short-term risk, KIDS is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check SILK's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
KIDS vs LMRI Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while LMRI trades at $11.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas LMRI's P/E ratio is -22.53. In terms of profitability, KIDS's ROE is -0.12%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, KIDS is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check LMRI's competition here
Paragon 28, Inc. (NYSE: FNA)
KIDS vs FNA Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas FNA's P/E ratio is -19.83. In terms of profitability, KIDS's ROE is -0.12%, compared to FNA's ROE of -0.35%. Regarding short-term risk, KIDS is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
KIDS vs BVS Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, BVS has a market cap of 956.9M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while BVS trades at $13.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas BVS's P/E ratio is 18.59. In terms of profitability, KIDS's ROE is -0.12%, compared to BVS's ROE of +0.28%. Regarding short-term risk, KIDS is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check BVS's competition here
InMode Ltd. (NASDAQ: INMD)
KIDS vs INMD Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, INMD has a market cap of 880M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while INMD trades at $15.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas INMD's P/E ratio is 10.63. In terms of profitability, KIDS's ROE is -0.12%, compared to INMD's ROE of +0.13%. Regarding short-term risk, KIDS is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check INMD's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
KIDS vs AVR Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, AVR has a market cap of 866.3M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while AVR trades at $9.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas AVR's P/E ratio is -4.00. In terms of profitability, KIDS's ROE is -0.12%, compared to AVR's ROE of -1.24%. Regarding short-term risk, KIDS is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check AVR's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
KIDS vs CSII Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas CSII's P/E ratio is -20.83. In terms of profitability, KIDS's ROE is -0.12%, compared to CSII's ROE of -0.14%. Regarding short-term risk, KIDS is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
KIDS vs SIBN Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, SIBN has a market cap of 825.3M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while SIBN trades at $19.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas SIBN's P/E ratio is -54.74. In terms of profitability, KIDS's ROE is -0.12%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, KIDS is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check SIBN's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
KIDS vs AHCO Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, AHCO has a market cap of 774.1M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while AHCO trades at $5.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas AHCO's P/E ratio is 11.61. In terms of profitability, KIDS's ROE is -0.12%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, KIDS is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
KIDS vs SSII Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, SSII has a market cap of 754.5M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while SSII trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas SSII's P/E ratio is -73.53. In terms of profitability, KIDS's ROE is -0.12%, compared to SSII's ROE of -0.23%. Regarding short-term risk, KIDS is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check SSII's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
KIDS vs BBNX Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, BBNX has a market cap of 715.3M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while BBNX trades at $16.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas BBNX's P/E ratio is -10.53. In terms of profitability, KIDS's ROE is -0.12%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, KIDS is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check BBNX's competition here
CeriBell, Inc. (NASDAQ: CBLL)
KIDS vs CBLL Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, CBLL has a market cap of 713.7M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while CBLL trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas CBLL's P/E ratio is -11.54. In terms of profitability, KIDS's ROE is -0.12%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, KIDS is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check CBLL's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
KIDS vs TCMD Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, TCMD has a market cap of 665.4M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while TCMD trades at $29.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas TCMD's P/E ratio is 33.52. In terms of profitability, KIDS's ROE is -0.12%, compared to TCMD's ROE of +0.10%. Regarding short-term risk, KIDS is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check TCMD's competition here
Surmodics, Inc. (NASDAQ: SRDX)
KIDS vs SRDX Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas SRDX's P/E ratio is -34.66. In terms of profitability, KIDS's ROE is -0.12%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, KIDS is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check SRDX's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
KIDS vs BWAY Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, BWAY has a market cap of 608M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while BWAY trades at $15.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas BWAY's P/E ratio is 39.38. In terms of profitability, KIDS's ROE is -0.12%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, KIDS is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check BWAY's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
KIDS vs APEN Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas APEN's P/E ratio is -9.43. In terms of profitability, KIDS's ROE is -0.12%, compared to APEN's ROE of -0.85%. Regarding short-term risk, KIDS is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check APEN's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
KIDS vs CTKB Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, CTKB has a market cap of 542.4M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while CTKB trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas CTKB's P/E ratio is -22.25. In terms of profitability, KIDS's ROE is -0.12%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, KIDS is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check CTKB's competition here
ZimVie Inc. (NASDAQ: ZIMV)
KIDS vs ZIMV Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, KIDS's ROE is -0.12%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, KIDS is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ZIMV's competition here
Varex Imaging Corporation (NASDAQ: VREX)
KIDS vs VREX Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, VREX has a market cap of 522.5M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while VREX trades at $18.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas VREX's P/E ratio is 13.06. In terms of profitability, KIDS's ROE is -0.12%, compared to VREX's ROE of -0.18%. Regarding short-term risk, KIDS is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check VREX's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
KIDS vs DCTH Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, DCTH has a market cap of 521.6M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while DCTH trades at $16.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas DCTH's P/E ratio is 1511.00. In terms of profitability, KIDS's ROE is -0.12%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, KIDS is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check DCTH's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
KIDS vs NPCE Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, NPCE has a market cap of 505.6M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while NPCE trades at $14.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas NPCE's P/E ratio is -25.57. In terms of profitability, KIDS's ROE is -0.12%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, KIDS is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check NPCE's competition here
Cerus Corporation (NASDAQ: CERS)
KIDS vs CERS Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, CERS has a market cap of 473.6M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while CERS trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas CERS's P/E ratio is -46.91. In terms of profitability, KIDS's ROE is -0.12%, compared to CERS's ROE of -0.10%. Regarding short-term risk, KIDS is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check CERS's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
KIDS vs CLPT Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, CLPT has a market cap of 426.2M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while CLPT trades at $14.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas CLPT's P/E ratio is -12.04. In terms of profitability, KIDS's ROE is -0.12%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, KIDS is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check CLPT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
KIDS vs OFIX Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, OFIX has a market cap of 415.5M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while OFIX trades at $10.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas OFIX's P/E ratio is -13.43. In terms of profitability, KIDS's ROE is -0.12%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, KIDS is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check OFIX's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
KIDS vs SGHT Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, SGHT has a market cap of 406.4M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while SGHT trades at $7.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas SGHT's P/E ratio is -13.34. In terms of profitability, KIDS's ROE is -0.12%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, KIDS is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check SGHT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
KIDS vs CARL Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, CARL has a market cap of 375.7M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while CARL trades at $13.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas CARL's P/E ratio is -9.66. In terms of profitability, KIDS's ROE is -0.12%, compared to CARL's ROE of -0.38%. Regarding short-term risk, KIDS is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
KIDS vs PACB Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, PACB has a market cap of 368.1M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while PACB trades at $1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas PACB's P/E ratio is -2.89. In terms of profitability, KIDS's ROE is -0.12%, compared to PACB's ROE of -49.62%. Regarding short-term risk, KIDS is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check PACB's competition here
CapsoVision, Inc. (NASDAQ: CV)
KIDS vs CV Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, CV has a market cap of 354.7M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while CV trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas CV's P/E ratio is -2.84. In terms of profitability, KIDS's ROE is -0.12%, compared to CV's ROE of +1.27%. Regarding short-term risk, KIDS is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check CV's competition here
Picard Medical, Inc. (AMEX: PMI)
KIDS vs PMI Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, PMI has a market cap of 349.2M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while PMI trades at $3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas PMI's P/E ratio is -2.83. In terms of profitability, KIDS's ROE is -0.12%, compared to PMI's ROE of +4.99%. Regarding short-term risk, KIDS is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check PMI's competition here
Electromed, Inc. (AMEX: ELMD)
KIDS vs ELMD Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, ELMD has a market cap of 348.5M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while ELMD trades at $42.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas ELMD's P/E ratio is 35.97. In terms of profitability, KIDS's ROE is -0.12%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, KIDS is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check ELMD's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
KIDS vs CATX Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, CATX has a market cap of 342.1M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while CATX trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas CATX's P/E ratio is -2.13. In terms of profitability, KIDS's ROE is -0.12%, compared to CATX's ROE of -0.42%. Regarding short-term risk, KIDS is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check CATX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
KIDS vs SMLR Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas SMLR's P/E ratio is 3.92. In terms of profitability, KIDS's ROE is -0.12%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, KIDS is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
KIDS vs TMCI Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, TMCI has a market cap of 308.8M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while TMCI trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas TMCI's P/E ratio is -5.06. In terms of profitability, KIDS's ROE is -0.12%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, KIDS is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check TMCI's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
KIDS vs SENS Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, SENS has a market cap of 293.4M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while SENS trades at $7.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas SENS's P/E ratio is -3.51. In terms of profitability, KIDS's ROE is -0.12%, compared to SENS's ROE of -1.66%. Regarding short-term risk, KIDS is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check SENS's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
KIDS vs ANIK Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, ANIK has a market cap of 286.7M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while ANIK trades at $20.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas ANIK's P/E ratio is 43.71. In terms of profitability, KIDS's ROE is -0.12%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, KIDS is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check ANIK's competition here
Profound Medical Corp. (NASDAQ: PROF)
KIDS vs PROF Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, PROF has a market cap of 269.3M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while PROF trades at $7.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas PROF's P/E ratio is -5.98. In terms of profitability, KIDS's ROE is -0.12%, compared to PROF's ROE of -0.56%. Regarding short-term risk, KIDS is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
KIDS vs RXST Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, RXST has a market cap of 259.1M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while RXST trades at $6.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas RXST's P/E ratio is -6.73. In terms of profitability, KIDS's ROE is -0.12%, compared to RXST's ROE of -0.17%. Regarding short-term risk, KIDS is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check RXST's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
KIDS vs MGRM Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas MGRM's P/E ratio is -12.00. In terms of profitability, KIDS's ROE is -0.12%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, KIDS is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check MGRM's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
KIDS vs FOCL Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, FOCL has a market cap of 233.1M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while FOCL trades at $6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas FOCL's P/E ratio is -8.00. In terms of profitability, KIDS's ROE is -0.12%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, KIDS is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check FOCL's competition here
Nevro Corp. (NYSE: NVRO)
KIDS vs NVRO Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas NVRO's P/E ratio is -1.91. In terms of profitability, KIDS's ROE is -0.12%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, KIDS is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check NVRO's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
KIDS vs TLSI Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, TLSI has a market cap of 212.7M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while TLSI trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas TLSI's P/E ratio is -3.34. In terms of profitability, KIDS's ROE is -0.12%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, KIDS is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check TLSI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
KIDS vs RCEL Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, RCEL has a market cap of 193M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while RCEL trades at $8.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas RCEL's P/E ratio is -4.95. In terms of profitability, KIDS's ROE is -0.12%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, KIDS is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check RCEL's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
KIDS vs BSGM Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas BSGM's P/E ratio is -5.81. In terms of profitability, KIDS's ROE is -0.12%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, KIDS is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check BSGM's competition here
Quanterix Corporation (NASDAQ: QTRX)
KIDS vs QTRX Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, QTRX has a market cap of 189.8M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while QTRX trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas QTRX's P/E ratio is -2.52. In terms of profitability, KIDS's ROE is -0.12%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, KIDS is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check QTRX's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
KIDS vs MDGS Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas MDGS's P/E ratio is -0.27. In terms of profitability, KIDS's ROE is -0.12%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, KIDS is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
KIDS vs STIM Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, STIM has a market cap of 165.6M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while STIM trades at $2.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas STIM's P/E ratio is -4.41. In terms of profitability, KIDS's ROE is -0.12%, compared to STIM's ROE of -1.65%. Regarding short-term risk, KIDS is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check STIM's competition here
Inogen, Inc. (NASDAQ: INGN)
KIDS vs INGN Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, INGN has a market cap of 163.8M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while INGN trades at $6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas INGN's P/E ratio is -6.65. In terms of profitability, KIDS's ROE is -0.12%, compared to INGN's ROE of -0.13%. Regarding short-term risk, KIDS is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check INGN's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
KIDS vs QIPT Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas QIPT's P/E ratio is -15.87. In terms of profitability, KIDS's ROE is -0.12%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, KIDS is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check QIPT's competition here
iCAD, Inc. (NASDAQ: ICAD)
KIDS vs ICAD Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas ICAD's P/E ratio is -20.37. In terms of profitability, KIDS's ROE is -0.12%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, KIDS is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check ICAD's competition here
Owlet, Inc. (NYSE: OWLT)
KIDS vs OWLT Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, OWLT has a market cap of 99.9M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while OWLT trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas OWLT's P/E ratio is -39.43. In terms of profitability, KIDS's ROE is -0.12%, compared to OWLT's ROE of +11.36%. Regarding short-term risk, KIDS is more volatile compared to OWLT. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check OWLT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
KIDS vs LUCD Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, LUCD has a market cap of 98.9M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while LUCD trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas LUCD's P/E ratio is -2.61. In terms of profitability, KIDS's ROE is -0.12%, compared to LUCD's ROE of -3.70%. Regarding short-term risk, KIDS is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for KIDS.Check LUCD's competition here
Solana Company (NASDAQ: HSDT)
KIDS vs HSDT Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, HSDT has a market cap of 98.7M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while HSDT trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas HSDT's P/E ratio is -0.02. In terms of profitability, KIDS's ROE is -0.12%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, KIDS is less volatile compared to HSDT. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check HSDT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
KIDS vs HJLI Comparison August 2026
OrthoPediatrics Corp. (NASDAQ: KIDS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIDS stands at 584.8M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, KIDS is priced at $23.19 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIDS currently has a P/E ratio of -19.30, whereas HJLI's P/E ratio is N/A. In terms of profitability, KIDS's ROE is -0.12%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, KIDS is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for KIDS.Check HJLI's competition here